Skip to main content

Table 6 Clinical Characteristics of Subjects at baseline and end of Study

From: Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting

  

Intervention group (IG)

Control Group (CG)

Variables

 

Baseline

After 6 Months

Mean difference (95% CI)

p-Value

Baseline

After 6 months

Mean difference (95% CI)

p-Value

Blood Pressure

SBP Mean

152.3

143.4

9.28 (12.79 to 5.79)

0.000

147.2

145.8

1.34 (4.95 to −2.28)

0.463

DBP Mean

87.6

78.5

9.040 (12.77 to 5.30)

0.000

90.7

91.2

−0.535 (1.77 to −2.84)

0.644

BMI

Mean

27.5

26.0

1.463 (2.33 to −0.59)

0.001

27.1

27.6

−0.098 (0.66 to −0.86)

0.798

Adherence

Mean

5.5

6.2

−0.693 (−0.08 to −1.30)

0.027

4.3

3.9

0.408 (0.765–0.052)

0.026

Smoking

n (%)

2 (2.7)

2 (2.7)

 

1.000

0 (0)

0(0)

 

1.102

Consumption of Salty foods

n (%)

28 (37.3)

15 (20.0)

 

0.011

19 (26.8)

16 (22.5)

 

0.508

Alcohol n (%)

Regular n (%)

8 (10.6)

2 (2.7)

 

0.000

9 (12.7)

3 (4.2)

 

.005

Exercise n (%)

n(%)

24 (32.0)

58 (77.3)

 

0.000

32 (45.1)

22 (31.0)

 

0.031